About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Ohio | 763 Studies

Clinical Trials LymphomaOhio

Lymphoma Clinical Trials in Ohio

Find 763 clinical trials for lymphoma near Ohio. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 763 trials

CompletedInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerPhase I trial to study the effectiveness of combining interleukin-12 and interferon alfa in treating patients who have residual, recurrent, or metastatic malignant melanoma or…NCT00003451·Columbus, Ohio CompletedTofacitinib Ointment For Chronic Plaque PsoriasisThe study is beng done to test if tofacitinib ointment is safe and effective for people with plaque psoriasis.NCT01831466·Hot Springs, Arkansas and 53 others

PreviousPage 16 of 39Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedVenetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic MalignanciesThis phase Ib trial studies the toxicity and dosing of venetoclax in combination with selinexor, and how well the combination works in treatment of patients with high risk…NCT03955783·Buffalo, New York and 3 others

TerminatedCord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic CancersThis phase II trial studies the side effects of a cord blood transplant using dilanubicel and to see how well it works in treating patients with human immunodeficiency virus (HIV)…NCT04083170·San Francisco, California and 4 others

TerminatedDonor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantRATIONALE: Giving chemotherapy, such as busulfan and fludarabine phosphate, before a peripheral blood stem cell transplant helps stop the growth of cancer cells.NCT01118013·Lewes, Delaware and 9 others

RecruitingA Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLThe goal of this clinical trial is to learn if drug GSK5926371 works to treat a form of B-cell cancer (a type of blood cancer) that has returned or failed to respond to prior…NCT07607925·Iowa City, Iowa and 21 others

CompletedChemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00020943·Anniston, Alabama and 80 others

CompletedS0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin LymphomaRATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 tositumomab, can find cancer cells and carry cancer-killing substances to them without harming normal cells.NCT00770224·Mobile, Alabama and 113 others

CompletedRituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS LymphomaRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.NCT00098774·San Francisco, California and 29 others

CompletedA Study of Patients With AIDS SyndromeThe purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients.NCT00001120·Menlo Park, California and 22 others

CompletedProleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan TreatmentsThe purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have…NCT00045877·Little Rock, Arkansas and 64 others

CompletedSingle Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood UnitThis trial is a prospective, open-label, single-arm trial of the safety of a single FT1050-treated CB unit for hematopoietic reconstitution after a reduced-intensity conditioning…NCT01527838·Boston, Massachusetts and 2 others

RecruitingA Study of LY4584180 in Adult Participants With Previously Treated Blood CancersThe main purpose of this study is to evaluate safety and efficacy, and measure how much LY4584180 gets into the bloodstream and how long it takes the body to eliminate it in…NCT07226843·Scottsdale, Arizona and 45 others

Active not recruitingIvosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well ivosidenib works in treating patients with solid tumors, including central nervous system tumors, lymphomas and histiocytic…NCT04195555·Birmingham, Alabama and 173 others

TerminatedLong-Term Follow-Up Study of Subjects Treated With ACTR T Cell ProductSubjects treated with an ACTR product may participate in this long-term follow-up study after the completion of the final scheduled visit in the parent clinical study or other…NCT02840110·Gilbert, Arizona and 15 others

CompletedArsenic Trioxide in Treating Young Patients With Refractory Leukemia or LymphomaRATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die.NCT00020111·Little Rock, Arkansas and 51 others

Active not recruitingA Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaThis is a Phase 1b/2, multicenter, open-label, study of JNJ-90014496, an autologous dual targeting chimeric antigen receptor (CAR) T-cell therapy targeting both cluster of…NCT05421663·Duarte, California and 31 others

CompletedAlisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin LymphomaThis phase II trial studies how well alisertib works in treating patients with peripheral T-cell non-Hodgkin lymphoma that has come back after a period of improvement or has not…NCT01466881·Mobile, Alabama and 160 others

Active not recruitingHuman AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid MalignanciesThe purpose of this study is to determine if it is possible to treat relapsed or refractory lymphoid malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic…NCT04732845·Cleveland, Ohio

CompletedCombination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy, such as doxorubicin, vinblastine, and gemcitabine, work in different ways to stop cancer cells from dividing so they stop growing or die.NCT00086801·San Francisco, California and 46 others

Other Conditions in Ohio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia